随机临床试验出版物中数据监测委员会的报告常不充分:ACTTION系统综述
该研究系统综述了2014年发表在六种高影响综合医学期刊上的随机临床试验(RCT) primary reports,考察是否报告使用了数据监测委员会/数据与安全监测委员会(DMC/DSMB)及其职责组成。在294篇文章中,174篇(59%)提及使用DMC/DSMB;其中126篇(72%)报告了至少一项职责,26%列出了成员姓名,另有14%同时列出姓名和所属机构;仅1篇声明未使用DSMB;其余119篇未报告是否使用,尽管其中59篇已在临床试验注册或已发表方案中声明将使用DMC/DSMB。作者建议RCT发表时应报告是否使用DMC/DSMB及其职责和成员,以提高研究实施的透明度。
要点
- 在294篇RCT报告中,174篇(59%)提及使用DMC/DSMB。
- 提及使用DMC/DSMB的174篇中,126篇(72%)报告了至少一项职责。
- 26%列出DMC/DSMB成员姓名,14%同时列出姓名和所属机构。
核心结论
- 考虑到DMC/DSMB在保护受试者安全、数据质量和期中分析中的重要作用,作者建议RCT发表时应报告是否使用DMC/DSMB以及DMC/DSMB的职责和成员,以提高研究实施的透明度。
研究设计与样本
- 系统综述,纳入2014年发表在Annals of Internal Medicine、BMJ、NEJM、JAMA、JAMA Internal Medicine和Lancet上的RCT primary reports,共识别294篇文章。
主要发现
- 294篇文章中,174篇(59%)提及使用DMC/DSMB。
- 提及使用DMC/DSMB的174篇中,126篇(72%)报告了至少一项DMC/DSMB职责。
- 26%列出了DMC/DSMB成员姓名,另有14%同时列出姓名和所属机构。
- 仅1篇文章声明未使用DSMB。
- 其余119篇文章未报告是否使用DMC/DSMB,尽管其中59篇已在临床试验注册或已发表方案中声明将使用DMC/DSMB。
临床怎么用
- 作者建议RCT发表时应报告是否使用DMC/DSMB以及DMC/DSMB的职责和成员,以提高研究实施的透明度。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine whether primary reports of randomized clinical trials (RCTs) in six high-impact, general medical journals reported (1) whether or not a Data Monitoring Committee/Data and Safety Monitoring Board (DMC/DSMB) was used and (2) the composition of the responsibilities of the reported DSMB/DMCs. STUDY DESIGN AND SETTING: Systematic review of RCTs published in 2014 in Annals of Internal Medicine, BMJ, NEJM, JAMA, JAMA Internal Medicine, and Lancet. RESULTS: Of the 294 articles identified, 174 (59%) mentioned using a DMC/DSMB. Of these 174, 126 (72%) indicated at least one responsibility of the DMC/DSMB, 26% listed the names of the DMC/DSMB members, and another 14% listed both their names and affiliations. Only one article stated that a DSMB was not used. The remaining 119 articles did not report whether or not a DMC/DSMB was used, although 59 had previously stated in a clinical trials registry entry or a published protocol that a DMC/DSMB was to be used. CONCLUSIONS: Considering the major role that DMC/DSMBs play in protecting participant safety, data quality, and interim analyses in RCTs, we recommend that authors of publications of RCTs report whether a DMC/DSMB was used and the responsibilities and members of DMC/DSMBs to increase transparency regarding study conduct.
引用
- Gewandter JS, Kitt RA, Hunsinger MR, et al. Reporting of data monitoring boards in publications of randomized clinical trials is often deficient: ACTTION systematic review. J Clin Epidemiol. 2017. PMID: 28126598. doi:10.1016/j.jclinepi.2016.12.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。